Upload
rahul-kunkulol
View
1.693
Download
2
Embed Size (px)
Citation preview
DR.RAHUL
Antiviral Agents
04/11/2023DR RAHUL KUNKULOL
1
VIRUSES Viruses are made up of core genome
of nucleic acid contained in a protein shell called Capsid
Surrounded by lipoprotein membrane called envelope (Genome + Capsid + Envelope = Virion)
Viruses are obligate intracellular parasite ie. do not have a metabolic machinery of their own – uses host enzymes
04/11/2023DR RAHUL KUNKULOL 2
VIRUSES• Certain viruses multiply in the
cytoplasm but others do in the nucleus
• Some viruses have unique enzymes for DNA/RNA synthesis or protein cutting in virus assembly.
• Most multiplication take place before diagnosis is made
04/11/2023DR RAHUL KUNKULOL 3
Types of Viruses• DNA viruses• Adenoviruses (upper respiratory infections)• Herpes simplex (genital herpes)• Hepadna virus (hepatitis B)• Cytomegalovirus (CMV)• Varicella (chickenpox) and varicella-zoster• Smallpox
• RNA viruses : Influenza A and B
• RNA retroviruses : Human immunodeficiency virus (HIV)
04/11/2023DR RAHUL KUNKULOL 4
Viral Replication
Adsorption to and penetration of susceptible cells.
Synthesis of early, nonstructural proteins.
Synthesis of RNA or DNA.
Synthesis of late, structural proteins
Assembly of viral particles and release
04/11/2023DR RAHUL KUNKULOL 5
DNA Viral replication cycle
04/11/2023 6
RNA Viral replication cycle
04/11/2023 7
Targets for Antivirals
04/11/2023DR RAHUL KUNKULOL
8
Viral uncoating
Nucleoside analogs
Non-nucleoside polymerase inhibitors
Non-nucleoside reverse transcriptase inhibitors
Protease inhibitors
Neuraminidase inhibitors
Anti-Viral drugsMany antiviral drugs are Purine or Pyrimidine analogs.Many antiviral drugs are Prodrugs. They must be phosphorylated by viral or cellular enzymes in order to become active.Anti-viral agents inhibits active replication The viral growth resumes after drug removal.
04/11/2023DR RAHUL KUNKULOL 9
Anti-viral drugsCurrent anti-viral agents do not eliminate non-replicating or latent virus
Effective host immune response remains essential for the recovery from the viral infection
Clinical efficacy depends on achieving inhibitory conc. at the site of infection within the infected cells
04/11/2023DR RAHUL KUNKULOL 10
ClassificationAll are DNA polymerase inhibitors
Nucleoside Analogues:(Herpes, CMV, HIV, R.Syncitial)
Purine analoguesAcyclovir ValacyclovirGanciclovir ValganciclovirPenciclovir FamciclovirCidofovir (c) Adefovir (a)
Vidarabine (a) Pyrimidine analogues
IdoxuridineTrifluridine
04/11/2023DR RAHUL KUNKULOL 11
Classification Non Nucleoside:(Herpes )
Foscarnet (Direct inhibitor of DNA polymerase and RT)
mRNA synthesis inhibitorRibavirin Fomivirsen
Inhibitors of viral uncoating: (Influenza)
Amantadine Rimantadine Neuraminidase inhibitor
Zanamavir Oseltamivir Non selective antivirals
Interferon-alpha (Hepat. B&C, Herpes)04/11/2023DR RAHUL KUNKULOL 12
Antiviral DrugsNucleoside and Nucleotide
Analogs
Figure 20.16a04/11/2023DR RAHUL KUNKULOL 13
Acyclovir & Congeners :
• Valacyclovir is a prodrug of Acyclovir with better bioavailability.
• Famciclovir is hydrolyzed to Penciclovir and has greatest bioavailability.
• Penciclovir is used only topically whereas Famciclovir can be administered orally.
• All are guanine nucleoside analogs.
04/11/2023DR RAHUL KUNKULOL 14
Acyclovir: Mechanism of Action
04/11/2023DR RAHUL KUNKULOL 15
Nucleoside AnaloguesGeneral Mechanism of Action
1. Taken up by cells
2. Converted by viral and cellualr enzymes to the triphosphate form
3. The triphosphate form inhibits:• DNA polymerase
• Reverse transcriptase
• RNA polymerase
4. Or it may get incorporated into growing DNA leading to abnormal proteins or breakage.
04/11/2023DR RAHUL KUNKULOL 16
Acyclovir Valacyclovir (prodrug, better availability)
A Guanine analogue with antiviral for Herpes group only
Acyclovir AcycloGMP AcycloGTP
Thymidine kinase Cellular kinases
Viral 200x affinityof mammalian
1. Inhibits viral DNA polymerase selectively2. Incorporated into DNA and terminates synthesis
04/11/2023DR RAHUL KUNKULOL 17
Active against HSV-1 (Labial
and ocular infection)
HSV-2 (Genital infection)
Varicella-zoster infections
Epstein barr virus
Resistance :HSV and varicella zosterDeficiency in
thymidine kinase activity
Changes in virus directed enzymes
Acyclovir (ACV)
04/11/2023DR RAHUL KUNKULOL 18
THERAPEUTIC USES
04/11/2023DR RAHUL KUNKULOL 19
Genital Herpes (HSV-II)
• Primary disease : • Acyclovir 5% ointment 6 times a
day for 10 days• Late & severe cases: 400 mg TDS
orally for 10 days • Recurrent disease:• Iv infusion 5mg/kg over 1 hr
repeated 8 hrly for 10 days• Followed by suppressive
treatment with oral acyclovir
04/11/2023DR RAHUL KUNKULOL 20
HSV-I
04/11/2023DR RAHUL KUNKULOL 21
• Mucocutaneous :• Remains localized to lips and
gums (Acyclovir skin cream)• H.Simplex encephalitis • 10 mg /kg /8hr iv acyclovir for 10
days• H. Simplex keratitis (HSV–I)• Acyclovir eye ointment 5 times a
day for 3days
Other uses…….
04/11/2023DR RAHUL KUNKULOL 22
Chickenpox : Oral 400mg TDS for 7 days
Herpes zoster infections Acyclovir less active
Adverse effects• Oral : • Headach, N/v, diarrhea, vertigo
• IV : • Phlebitis, rash , hypotention• Nephrotoxicity
• Reversible neurological manifestations
04/11/2023DR RAHUL KUNKULOL 23
Ganciclovir
• Mechanism like Acyclovir • Active against all Herpes viruses
including CMV• Low oral bioavailability given I.V.• Drug of choice for CMV
infections: retinitis, pneumonia, colitis…
04/11/2023DR RAHUL KUNKULOL 24
Adverse effects
Bone marrow suppression (leukopenia 40%,
thrombocytopenia 20%) CNS effects
(headache, behavioral, psychosis, coma, convulsions) 1/3 of patients have to stop because
of adverse effects
04/11/2023DR RAHUL KUNKULOL 25
Guanine
Acyclovir Ganciclovir
04/11/2023DR RAHUL KUNKULOL
26
Cidofovir Approved for the treatment of CMV retinitis in immunocompromised patients Nucleoside analog of cytosine Gets converted to only cidofovir
diphosphate and inhibit viral DNA polymerase
It inhibits viral DNA synthesisAvailable for IV, Intravitreal inj, TopicalNephrotoxicity is a major disadvantage.Uses : CMV retinitis
04/11/2023DR RAHUL KUNKULOL 27
AdefovirAdenosine analogue
Converted by cellular kinases to active diphosphate
Inhibits Hepatitis B virus DNA polymerase
Gets incorporated into DNA causes Chain termination
Use: Chronic hepatitis B
AE : Nephrotoxicity, lactic acidosis, hepatomegaly.
04/11/2023DR RAHUL KUNKULOL 28
Vidarabine Adenine nucleoside analogue Convert to Ara-A triphosphate and
inhibit DNA polymerase Active against HSV and vaccina virus
› Treatment of HSV encephalitis and herpetic keratitis
Poor solubility, given i.v. with big volume of fluids (2.5 L) ⇒ risk of fluid overload
04/11/2023DR RAHUL KUNKULOL 29
ADVERSE EFFECTS
GI Bone marrow Hypokalemia Inappropriate ADH secretion; Psychosis; painful neuropathy; Not a drug of choice for anything :
Replaced by Acyclovir because of toxicity and problems in administration.
04/11/2023DR RAHUL KUNKULOL 30
Idoxuridine( IDU)
• Active against HSV and VZV• First pyrimidine analogue used as
antiviral.• It is iodinated derivative of
deoxyuridine.• MOA same as acyclovir
04/11/2023DR RAHUL KUNKULOL 31
Uses• Topical use for treatment of HSV
infections of the eyelid, cornea and skin.• Only indication-
Herpes simplex kerato-conjunctivitis• High toxicity :• Bone marrow depression
• Due to incorporation of idoxuridine into host cell DNA
04/11/2023DR RAHUL KUNKULOL 32
Direct inhibitor of DNA polymerase and RT :
Foscarnet
• An inorganic pyrophosphate analog
• Active against Herpes (I, II), Varicella , CMV, including those resistant to Acyclovir and Ganciclovir.
• Direct inhibition of DNA polymerase and RT
• Very poor oral bioavalibility so given slow iv.
04/11/2023DR RAHUL KUNKULOL 34
Uses
• CMV retinitis and other CMV infections instead of Ganciclovir.
• H simplex resistant to Acyclovir
• H. simplex in AIDS patients
04/11/2023DR RAHUL KUNKULOL 35
Adverse effects• Nephrotoxicity (25%) most
common ADR• Hypocalcaemia (chelates divalent
cations)• Others: Hypokalemia,
Hypomagnesaemia
04/11/2023DR RAHUL KUNKULOL 36
Ribavirin
Inhibit replication of both DNA and RNA viruses
Triphosphate inhibits RNA polymerase
Anemia due to hemolysis and BM suppression
04/11/2023DR RAHUL KUNKULOL 37
Uses
Ribavirin is the drug of choice for:• RSV bronchiolitis and pneumonia in
hospitalized children (given by aerosol)
Ribavirin is an alternative drug for:• Influenza, Parainfluenza, Measles
virus infection in immunocompromised patients
04/11/2023DR RAHUL KUNKULOL 38
Fomivirsen• Is a Oligonucleotide
• Primarily an anti CMV agent
• Binds to mRNA and inhibit synthesis of immediate early proteins needed for replication
• Injected intravitreally for : CMV retinitis in patients of AIDS
• A/E: Iritis, Vitreitis.
04/11/2023DR RAHUL KUNKULOL 39
Antiviral Therapies for Influenza
04/11/2023DR RAHUL KUNKULOL 40
Viral uncoating inhibitors
Amantadine Rimantadine
• Chemically a tricyclic amine not related to any nucleotide
• Inhibit penetration of virus to cells ,the uncoating of certain virus and viral replication.
• M2 protein which acts as ion channell appears to be its one of the target.
• Prevent diseases caused by influenza A
• Treatment of Parkinson’s disease
04/11/2023DR RAHUL KUNKULOL 42
Adverse effects• GI upset• Headache• Nervousness• Postural hypotension, ankle edema
04/11/2023DR RAHUL KUNKULOL 43
• Inhibit neuraminidase enzyme of influenza• Enzyme essential for release of virus
• Examples: zanamivir and oseltamivir• Zanamivir administered via inhalation• Oseltamivir administered orally• Oseltamivir is converted to O.
carboxylate (oral bioavalibility 80%)
Neuraminidase inhibitor
04/11/2023DR RAHUL KUNKULOL
44
Uses and Adverse effects
• Therapeutic Use• Treatment of acute uncomplicated
Influenza A (H1N1 virus, swine flu) : Oseltamivir 75mg BD
• Prevention : 75mg OD
• Adverse effects• N/V, Bronchospasm and
abnormal respiratory function
04/11/2023DR RAHUL KUNKULOL 45
Interferons
• Three classes of interferons – α , β, γ • α and β interferons: produced by all
the cells in response to viral infections• γ interferon : produced only by T
lymphocyte and NK cells in response to cytokines – immune regulating effects
• γ has less anti-viral activity compared to α and β interferon
04/11/2023DR RAHUL KUNKULOL 46
Mechanism of action
Induction of the following enzymes:A protein kinase which inhibits protein synthesisAn oligo-adenylate synthase which leads to degradation of viral mRNAA phosphodiesterase which inhibit t-RNA
The action of these enzymes leads to an inhibition of translation
04/11/2023DR RAHUL KUNKULOL 47
Interferons
• Interferon prevent spread of viruses to new cells (Viral hepatitis)
• Natural products of the immune system in viral infections
• Antiviral, anticancer and immuno-modulating
• Toxicity: flu-like syndrome, BM suppression; CNS
• Use :Hepatitis B and C04/11/2023DR RAHUL KUNKULOL 48
Antivirals Spectrum
Acyclovir HSV-1, HSV-2, VZV, Shingles.
Ganciclovir CMV
Famciclovir Herpes genitalis, shingles
Cidofovir CMV
Adefovir HBV
Idoxuridine, Trifluridine
Herpetic keratoconjunctivitis
04/11/2023DR RAHUL KUNKULOL 49
Antivirals Spectrum
Foscarnet HSV, CMV in AIDS
Ribavirin RSV, Parainfluenza
Fomivirsen CMV retinitis in AIDS
Amantidine, Rimantidine
Influenza A Virus
Oseltamivir H1N1 influenza
Interferon HBV, HCV04/11/2023DR RAHUL KUNKULOL 50
Virus
DiseasesDrug(s) of choice
Alternative drugs
Inf. A
Influenza
Amantadine Rimantadine
RSVPneumonia,bronchiolitis
Ribavirin(aerosol)
HSV
Genital herpes
Acyclovir
Foscarnet
Keratitis
Conjunctivitis
TrifluridineIdoxuridineVidarabine
Encephalitis
Acyclovir
Neonatal HSV
infection
Acyclovir
Vidarabine
Herpes infections in
immuno- compromised host
Acyclovir
Foscarnet
04/11/2023DR RAHUL KUNKULOL
51
In normal host
No therapy
Immunocompromised host, or pregnancy
Acyclovir
Foscarnet
CMV
Retinitis
Ganciclovir
Foscarnet
HCV
InterferonsHepatitis B
Hepatitis C
VZV
CMV
04/11/2023DR RAHUL KUNKULOL
52
HBV
Recent...... ENTECAVIR:• Guanosine analogue
• Competitively inhibits viral DNA polymerase
• Approved by FDA in march 2005 for treatment of chronic hepatitis B
• Oral bioavailibility : 95%
• AE : Headach, fatigue, NV
04/11/2023DR RAHUL KUNKULOL 53
Recent...... Peramivir• Neuramidase inhibitor
• Approved in 2009
• For emergency treatment of hospitalised patients of H1N1 infection
• Used iv for patients resistant to Oseltamivir, zanamivir….
04/11/2023DR RAHUL KUNKULOL 54